The slide "Current Challenges & Needs" outlines original issues in compound testing, including low throughput, high costs, long turnaround times, limited in vivo predictivity, high animal use, and resource intensity. It contrasts these with solutions like scalable in vitro assays, reduced costs and time, improved predictivity, and animal-free testing, illustrated by a high-throughput screening workflow figure.
Current Challenges & Needs
| Original Challenges | Addressing Needs |
|---|
| • Low throughput (few compounds/week)
- High cost per compound
- Long turnaround times
- Limited predictivity for in vivo outcomes
- High animal use
- Resource intensive | [Figure: High-throughput screening workflow]
🔬 Lab pipette 🧫 Cell cultures
- Scalable in vitro assays
- Reduced costs & time
- Improved predictivity
- Animal-free testing |
Source: High-throughput In Vitro Methods for Genotoxicity Testing - Noah Banholzer
Speaker Notes
Highlight key bottlenecks in current genotoxicity testing: low throughput, high costs, and limited predictivity. Transition to how high-throughput methods address these with innovative in vitro approaches.